The global intragastric balloons market is expected to grow at a CAGR of more than 7.01% till 2021.
Global Intragastric Balloons Market - Strategic Assessment and Forecast till 2021 market research report considers the present scenario of worldwide intragastric balloons market and forecasts the growth of the market till 2021.
Intragastric balloons are the saline-filled silicone balloons placed in the stomach for a span of months and limits intake of food by giving the feeling of satiety. These balloons permit patients to sense fullness, controls hunger, delays gastric emptying by altering gut hormones and peptides thus reducing food intake ultimately.
The research report gives an in- depth analysis of the market growth, trends, driver and restraints associated with it. The report gives a detailed analysis of the intragastric balloons
By Geography
• Americas
• Europe Middle East and Africa (EMEA)
• Asia-Pacific (APAC)
•
By Countries
• Africa
• Australia
• Brazil
• Canada
• China
• France
• Germany
• India
• Italy
• Japan
• Korea
• Middle East (Saudi Arabia, Qatar, Kuwait)
• New Zealand
• Spain
• UK
• US
The report also provides market share and profiles the key vendors operating in the Worldwide Intragastric Balloons Market and also provides the detailed competitive landscape of key players.
Intragastric Balloons Market – Market size and Dynamic
The market research analyst at Beige Market Intelligence expects the global intragastric balloons market to reach approx. US$198.56 million by 2021, growing at a CAGR of 7.01% during the forecast period 2016-2021. A large portion of the US healthcare expenditure is spent on programmes related to chronic diseases like obesity. Owing to this, the adoption of intragastric balloons is expected to propel in the U.S. to manage obesity. Europe, Middle East, and Africa (EMEA) accounts for the major share of the market.
Intragastric Balloons Market – Trends and Drivers
This market research report provides market overview of the factors driving and restraining the growth of the market. The report also outlines the key trends emerging in the market that will contribute to the growth of Intragastric Balloons Market during the forecast period. Today, intragastric balloons are used as treatment for obesity as a pre-emptive therapy, a metabolic therapy, or a primary therapy. Intragastric balloons help in weight loss and helps in recovering metabolic diseases. Factors such as large obese population, unhealthy lifestyle, short hospital stay, short recovery time, and low price of intragastric ballooning globally are driving the growth of the market.
There a short- term and long term risks and adverse effects associated with the use of intragastric balloons which is one of the major impeding challenges for the intragastric balloons market.
Intragastric Balloons Market – Geographical Analysis
The report includes the market analysis of different regions such as Americas, APAC, and Europe and MEA. The report outlines the major market share holder and the market size analysis of all the regions. Europe, Middle East and Africa (EMEA) is expected to continue dominating the intragastric balloons market in near future with a market share of approx.. 62% in 2021. In EMEA, the EU5 dominates the market with a collective share of about 91.5% in 2015 The US is the nascent market for intragastric ballooning with the first US FDA approval of intragastric ballooning in mid-2015. Mexico is likely to spur the growth of the intragastric balloons market in the Latin American region.
Intragastric Balloons – Key Market Share and Vendor Analysis
This market research profiles the major companies in the Worldwide Intragastric Ballons Market and also provides the competitive landscape and market share of key the players. The report covers the entire market outlook regarding the value chain operating within the market.
Major Players in the market
• Apollo Endoscopy Inc.
• Spatz FGIA Inc.
• Allurion Technologies Inc.
• ReShape Medical Inc.
• Hélioscopie SA
• Obalon Therapeutics Inc.
Other Prominent Vendors are
• Silimed Inc.
• Endalis
• Obalon Therapeutics Inc
• BAROnova Inc.
• Districlass Medical SA
• MEDSIL
• PlenSat, Inc.
• LIFE PARTNERS EUROPE
• Medicone
• Fengh Medical
• Phagia Technologies, Inc.
• Shandong Institute of Medical Instruments
• Tulip Medical
Why should you buy Intragastric Balloons Market Report?
The report gives reasonable answers for the following questions which leads you to know the in- depth market analysis such as
1) How has the market been performing and what are some of the current changes which are expected to change the landscape in the coming years?
2) What are the various factors that can affect the market and in what way over the next few years?
3) What are the emerging trends and challenges for the market over the next five years?
4) Which regions are going to have the largest market share and what are the factors propelling the market growth in that region?
5) Which companies are the key vendors in the market?
6) What are the strategies used by the top vendors, and what are the opportunities to grow?
7) Which companies are the emerging vendors in the market?
CONTENTS
Section 1 Research Methodology
Section 2 Executive Summary
2.1 Key Market Facts
2.2 Geographical Scenario
2.3 Vendors in the Market
Section 3 Report Coverage
3.1 Scope of Study
3.2 Base Year
3.3 Assumptions
Section 4 Market Research Methodology
4.1 Geographical Segmentation
4.2 Vendor Segmentation
4.3 Currency Conversion Rates
Section 5 Introduction
5.1 Obesity
5.2 Morbid Obesity
5.3 BMI Ranges
5.4 Weight Loss
5.5 Introduction of Intragastric Balloons
5.6 Noteworthy Products in the Market
5.7 Advantages of Intragastric Balloons
5.8 Complications Associated with Intragastric Balloons
5.8.1 Minor Complications
5.8.2 Major Complications
5.9 Suitability of Intragastric Ballooning
5.9.1 Who is not fit for intragastric ballooning?
Section 6 Market Landscape
6.1 Market Overview
6.2 Product Innovations/Technologies
6.3 Vendors in the Market
Section 7 Key Market Growth Drivers
7.1 Assessment of Market Growth Drivers
Section 8 Key Market Restraints
8.1 Assessment of Market Restraints
Section 9 Key Market Trends
Section 10 Key Market Growth Opportunity
Section 11 Value Chain Analysis
Section 12 Evidence-based Research Studies
Section 13 Worldwide Intragastric Balloons Market by Geography
13.1 Key Insights
Section 14 Intragastric Balloons Market in the Americas
14.1 Penetration of Intragastric Balloons in the US
14.1.1 Obesity Rates in the US
14.1.2 Procedures Adopted in the US for Weight Loss
14.1.3 Intragastric Balloons Penetrate the US Market in 2015
14.1.4 Role of the Affordable Care Act in Obesity Prevention
14.2 Penetration of Intragastric Balloons in Canada
14.2.1 Obesity rates in Canada
14.2.2 High Healthcare Expenditure of Canada
14.2.3 Government's Role to Address Childhood Obesity in Canada
14.3 Penetration of Intragastric Balloons in Brazil
14.3.1 Obesity Rates in Brazil
14.3.2 Government Initiatives in Brazil
14.4 Penetration of Intragastric Balloons in Rest of the Americas
Section 15 Intragastric Balloons Market in EMEA
15.1 Penetration of Intragastric Balloons in Europe
15.1.1 Obesity Rates across countries in Europe
15.1.2 Changes in Eating Habits
15.1.3 Economic Burden of Obesity on Europe
15.1.4 European Parliament Initiative to Tackle Increasing Obesity in Europe
15.2 Penetration of Intragastric Balloons in Germany
15.2.1 Obesity Rates in Germany
15.2.2 Eating Habits
15.2.3 Government Initiatives
15.3 Penetration of Intragastric Balloons in the UK
15.3.1 The 'Fat Man of Europe'
15.3.2 Obesity Rates in the UK
15.3.3 Weight Loss Procedures in the UK
15.3.4 Cost of Weight Loss Procedures in the UK
15.3.5 Opportunities for Intragastric Balloons in the UK
15.4 Penetration of Intragastric Balloons in France
15.4.1 Obesity Rates in France
15.4.2 Weight Loss Procedures in France
15.5 Penetration of Intragastric Balloons in Italy
15.5.1 Obesity Rates in Italy
15.6 Penetration of Intragastric Balloons in Spain
15.6.1 Obesity Rates in Spain
15.7 Penetration of Intragastric Balloons in RoE
15.8 Penetration of Intragastric Balloons in the Middle East
15.8.1 Rise in Consumption of Fast Food
15.8.2 Extreme Outdoor Temperature
15.8.3 High Obesity Rates
15.8.4 Deaths due to Obesity-related NCDs and Opportunities for Intragastric Ballooning
15.9 Penetration of Intragastric Balloons in Africa
15.9.1 Transition in Food Habits
15.9.2 Obesity Rates
15.9.3 Obesity-related diseases ranked 2nd for Deaths
15.9.4 Costs of Weight Loss Procedures in Africa
Section 16 Intragastric Balloons Market in APAC
16.1 Penetration of Intragastric Balloons in Japan
16.1.1 Obesity Rates in Japan
16.1.2 Government Initiatives in Japan
16.1.3 Evidence-based Study for Intragastric Ballooning in Japan
16.2 Penetration of Intragastric Balloons in China
16.2.1 Obesity Rates in China
16.2.2 Obesity-related Diabetes in China
16.2.3 Bariatric Procedures in China
16.2.4 Government Initiatives
16.2.5 Opportunities for Intragastric Balloons
16.3 Penetration of Intragastric Balloons in India
16.3.1 Obese Population in India
16.3.2 Bariatric Procedures in India
16.3.3 Medical Tourism in India
16.4 Penetration of Intragastric Balloons in Rest of APAC (RoAPAC)
16.4.1 Penetration of Intragastric Balloons in Australia
16.4.2 Penetration of Intragastric Balloons in New Zealand
16.4.3 Penetration of Intragastric Balloons in Korea
Section 17 Changing Regulatory Landscape in Europe
17.1 Current Legislation
17.2 Implementing Measures
17.3 Revision of the Regulatory Framework
17.3.1 Objectives of the Revision
17.4 Implications of Revised Regulatory Framework on Intragastric Balloons Market in Europe
Section 18 Vendor Landscape
18.1 Silimed Inc.
18.2 Endalis
18.3 Obalon Therapeutics Inc.
18.4 BAROnova Inc.
18.5 Districlass Medical SA
18.6 MEDSIL
18.7 PlenSat Inc.
18.8 Life Partners Europe
18.9 Medicone
18.10 Fengh Medical
18.11 Phagia Technologies Inc.
18.12 Shandong Institute of Medical Instruments
18.13 Tulip Medical Ltd.
Section 19 Market Share Analysis
19.1 Apollo Endosurgery Inc.
19.2 Hélioscopie SA
19.3 MEDSIL
19.4 Spatz FGIA Inc.
Section 20 Competitive Landscape
Section 21 Key Vendor Analysis
21.1 Apollo Endoscopy Inc.
21.1.1 About the Company
21.1.2 Product Offerings
21.1.3 Strengths
21.1.4 Opportunity
21.2 Spatz FGIA Inc.
21.2.1 About the Company
21.2.2 Product Offerings
21.2.3 Strengths
21.2.4 Opportunity
21.3 Allurion Technologies Inc.
21.3.1 About the Company
21.3.2 Product Offerings
21.3.3 Strengths
21.3.4 Opportunity
21.4 ReShape Medical Inc.
21.4.1 About the Company
21.4.2 Product Offerings
21.4.3 Strengths
21.4.4 Opportunity
21.5 Hélioscopie SA
21.5.1 About the Company
21.5.2 Product Offerings
21.5.3 Strengths
21.5.4 Opportunity
Section 22 Summary of the Report
Section 23 Appendix
23.1 List of Abbreviations
?
EXHIBITS
Exhibit 1 Segmentation of Intragastric Balloons Market
Exhibit 2 Market Size Calculation - Bottom-up Approach
Exhibit 3 Market Size Calculation - Top-down Approach
Exhibit 4 Currency Conversion Chart
Exhibit 5 Worldwide Intragastric Balloons Market 2015-2021 (US$ Million)
Exhibit 6 Percentage of Obese Population across Countries, 2015
Exhibit 7 Average Cost of Intragastric Balloon Treatment across Countries
Exhibit 8 Assessment of Market Growth Drivers 2015
Exhibit 9 Assessment of Market Restraints 2015
Exhibit 10 Value Chain Analysis
Exhibit 11 Evidence-based Research Studies for Intragastric Balloons Market
Exhibit 12 Worldwide Intragastric Balloons Market by Geography
Exhibit 13 Intragastric Balloons Market in the Americas 2015 to 2021 (US$ Million)
Exhibit 14 Estimate of Bariatric Surgery Numbers in the US (2011-2015)
Exhibit 15 Percentage of Obese Population (Self-reported) in Canada 2014
Exhibit 16 Changes in Volume of Different Types of Bariatric Procedures Performed in Canadian Hospitals (2006–2014)
Exhibit 17 Intragastric Balloons Market in EMEA 2015-2021 (US$ Million)
Exhibit 18 Current Percentage of Obesity in Europe
Exhibit 19 Intragastric Balloons Market in EMEA Market Share by Country (2015)
Exhibit 20 Intragastric Balloons Market in Europe by Market Share in EU5 Countries (2015)
Exhibit 21 Intragastric Balloons Market in Germany 2015-2021 (US$ Million)
Exhibit 22 Intragastric Balloons Market in the UK 2015-2021 (US$ Million)
Exhibit 23 Intragastric Balloons Market in France 2015-2021 (US$ Million)
Exhibit 24 Intragastric Balloons Market in Italy 2015-2021 (US$ Million)
Exhibit 25 Intragastric Balloons Market in Spain 2015 to 2021 (US$ Million)
Exhibit 26 Intragastric Balloons Market in RoE 2015-2021 (US$ Million)
Exhibit 27 Intragastric Balloons Market in the Middle East 2015-2021 (US$ Million)
Exhibit 28 Intragastric Balloons Market in Africa 2015-2021 (US$ Million)
Exhibit 29 Intragastric Balloons Market in APAC 2015-2021 (US$ Million)
Exhibit 30 Annual Changes of Number of Laparoscopic Bariatric Procedures in Japan (200-2012)
Exhibit 31 Cost of Weight-loss Surgeries in the US v/s India in US$
Exhibit 32 Obese/Overweight Statistics in Australia (In Millions)
Exhibit 33 Cost of Intragastric Ballooning in Australia, by Program
Exhibit 34 Costs of Bariatric Surgeries in Australia
Exhibit 35 Percentage of Obese Population in New Zealand
Exhibit 36 Child Obesity Rates in Korea 2000-2020
Exhibit 37 Regulatory Landscape for Medical Devices in Europe
Exhibit 38 Volume Sold of Intragastric Balloons 2014
Exhibit 39 Descriptive Summary of Worldwide Intragastric Balloons market
Exhibit 40 Summary of worldwide Intragastric Balloons Market by Geography 2015-2021 (US$ Million)
Exhibit 41 Summary of Intragastric Balloons Market in EMEA by country 2015-2021 (US$ Million)
